原料辞典検索/simmondsia-chinensis-seed-oil/SIMMONDSIA CHINENSIS SEED OIL
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
植物由来 (Plant)

SIMMONDSIA CHINENSIS SEED OIL

標準 INCI 準拠: SIMMONDSIA CHINENSIS SEED OIL
ヘアコンディショニング剤皮膚コンディショニング剤エモリエント剤
[EU CosIng Official Definition] Simmondsia Chinensis Seed Oil is the fixed oil expressed or extracted from seeds of the desert shrub, Jojoba, Simmondsia chinensis, Buxaceae
結論先行 エグゼクティブ規制・安全性ファクトボックスAEO / GEO CITATION ANCHOR

化粧品における SIMMONDSIA CHINENSIS SEED OIL のグローバル配合基準と処方特性とは?

SIMMONDSIA CHINENSIS SEED OIL(CAS番号: 90045-98-0)は、化粧品処方において主にヘアコンディショニング剤, 皮膚コンディショニング剤, エモリエント剤として配合される原料です。日本厚労省/JCIA(規制なし)、韓国MFDS(規制なし)、欧州CosIng(規制なし)など6大法域の法定基準下で管理され、通常 1–6%(適正安定域 pH 4–8)で処方されます。

7大トラック 国別・用途別 公式全成分表示名称マトリクス

各国公的告示原典のみ収録 · 機械翻訳・任意音訳ゼロ
7-Track Official Statutory Label Names for SIMMONDSIA CHINENSIS SEED OIL
法域・規制トラック公式全成分表示名称ワンクリックコピー
① 韓国 (MFDS 化粧品標準名称)SIMMONDSIA CHINENSIS SEED OIL (KR MFDS Registered)
② 韓国旧名称履歴 (301 リダイレクト)——
③ 欧州連合 (EU CosIng EC 1223/2009)SIMMONDSIA CHINENSIS SEED OIL
④ 米国一般化粧品 (US PCPC / MoCRA INCI)SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL
⑤ 米国 FDA OTC モノグラフ有効成分名— (米国 OTC 対象外 / 一般化粧品原料)—
⑥ 中国 (NMPA IECIC 標準中国語名称)未収載 — 中国《既使用化粧品原料目録 (IECIC)》未収載—
⑦ 日本化粧品表示名称 / 医薬部外品外原規名称 (JCIA / MHLW)SIMMONDSIA CHINENSIS SEED OIL (標準INCI参照 · 任意カタカナ音訳排除)

Layer 1 — 6大法域 法定配合上限および規制ステータス

Layer 1 Statutory Regulatory Limits Across 6 Regions for SIMMONDSIA CHINENSIS SEED OIL
法域規制ステータス配合上限制限条件および一次法源出典
韓国 (MFDS)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
欧州 (EU)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
米国 (FDA)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
中国 (NMPA)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
日本 (MHLW)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
ASEAN (ACD)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
⚠️ 参考用案内 (免責事項): 本辞典の成分名・規制上限・処方ガイドは研究開発の参考用です。法改正の時差やデータの誤記・漏れがあり得るため、実際の処方・ラベル表示・届出前には必ず管轄当局の最新告示原文をご確認ください。本情報の利用により生じた問題について運営主体は法的責任を負いません。
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Sunscreen / Colorn=5
Min 1% · Q1 1% · Median 4% · Q3 5% · Max 6%
Sunscreen / Color — Sun care & color cosmetics dispersion / sensory modifier
Verified Source: Global Starter Formulation Library Statistical Distribution (n=5, EVONIK 3 · GRANT 2) (cir_safety) · EVONIK 3 · GRANT 2
Typical Median: 4%

Layer 3 — 剤形別通常配合濃度 (四分位数 n≥5) & 物理化学・相溶性ガイド

Layer 3 Formulation Concentration Quartiles by Product Category for SIMMONDSIA CHINENSIS SEED OIL
剤形グループMin – Q1 – Median – Q3 – Max (%)処方役割・作用機序Source ID
剤形群 D — 日焼け止め (UV)・メイクアップ・ファンデーション1% · 1% · 4% · 5% · 6%Sun care & color cosmetics dispersion / sensory modifierGlobal Starter Formulation Library Statistical Distribution (n=5, EVONIK 3 · GRANT 2)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Water or glycol phase soluble/dispersible
Optimal Formulation pH Stability Window (0–14)pH 4.0 – 8.0
0245.5791114

Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 50°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 50°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ Verify phase compati…SIMMONDSIA CHINENS…
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

代表商品名参考 (商標法第90条第1項第2号 記述的表示)
SIMMONDSIA CHINENSIS SEED OIL

商品名は研究者がグレードを識別するための参考表記であり、各商標権は原メーカーに帰属します。

学術・毒性・処方統合モノグラフ

Tier 1 Synthesis

本原料に紐づく NIH PubMed 査読付き論文アブストラクトおよび公的毒性評価報告書のみに基づいて作成された学術要約です。

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: SIMMONDSIA CHINENSIS SEED OIL | CAS No.: 90045-98-0 | EC No.: 289-964-3 - Origin: PLANT | Functions: , , - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: non-ionic | CosIng/MFDS - Official Regional Label Names: US [SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL] · EU [SIMMONDSIA CHINENSIS SEED OIL] · CN [-] · JP [-] · JP Quasi-Drug [-] ■ [2. Dermatological Mechanism of Action & Functional Role] - Simmondsia Chinensis Seed Oil is the fixed oil expressed or extracted from seeds of the desert shrub, Jojoba, Simmondsia chinensis, Buxaceae Classified under origin 'plant', it acts within the cosmetic vehicle or stratum corneum to deliver , , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: NONE | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. Unlisted (-)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): Quantum satis (QS) within standard cosmetic safety margins ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [sun_color] Typical range: 1.0 ~ 6.0% (Median 4.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=5, EVONIK 3 · GRANT 2)) — Sun care & color cosmetics dispersion / sensory modifier ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water Phase or Cool-down Phase (< 45°C) - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: SIMMONDSIA CHINENSIS SEED OIL ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 41757774 (2026, J Craniofac Surg): A Translational Cell-Culture Study of Jojoba Oil: Potential Uses and Safety Considerations for Nasal Applications - PMID 23923639 (2013, Pharmazie): Evaluation of the mechanism of gelation of an oleogel based on a triterpene extract from the outer bark of birch

関連査読付き学術論文 (NIH PubMed) (2)

A Translational Cell-Culture Study of Jojoba Oil: Potential Uses and Safety Considerations for Nasal Applications [PMID: 41757774 · 2026]
S&#xfc;nnet&#xe7;i G, Bayar Muluk N, Acar TY, Bulbul MV, Keskin &#x130;, Alaskarov E, Cingi C · J Craniofac Surg (2026)

The effects of Simmondsia chinensis seed oil on human nasal epithelial cells were the focus of this investigation. Nasal epithelial samples were obtained from physiologically sound tissue, as is customary in septorhinoplasty. As soon as the nasal epithelial tissues were received in the laboratory, they were processed. To remove residual blood and potential microbiological contaminants, the specimens were washed multiple times with phosphate-buffered saline (PBS) containing a 2% (v/v) antibiotic-antimycotic solution. The tissue pieces were then concentrated by centrifugation. The effects of Simmondsia chinensis seed oil on cell viability were evaluated by quantifying cellular metabolic activity using the MTT colorimetric assay. Afterward, cells were exposed to Simmondsia chinensis seed oil at concentrations of 1, 5, 15, 25, 50, 75, and 100&#xa0;&#xb5;L per well for a continuous 24-hour incubation period. The inhibitory curve was well-defined in the quantitative dose-response model that used nonlinear regression. A logIC&#x2085;&#x2080; value of 0.8681 was used to compute the estimated half-maximal inhibitory concentration (IC&#x2085;&#x2080;), which was found to be 7.3 &#xb5;L. The high level of reliability and reproducibility in the association between oil exposure volume and the observed reduction in cell viability is supported by the strong model fit (R&#xb2;=0.9055). Analysis of metabolic activity in cells exposed to Simmondsia chinensis seed oil showed a strong inhibitory effect that increased with increasing oil concentration. Cell viability was expressed relative to untreated cells, which were assigned a reference value of 100%. A steady decline in viability was observed across the entire dose range evaluated, indicating that the oil's cytotoxic effects were strongly concentration-dependent. A statistical comparison was conducted to confirm these findings. The results showed that cell viability was significantly reduced at all tested exposure levels of Simmondsia chinensis seed oil compared with the negative control group. In addition, there was a strong dose-dependent cytotoxic effect, as statistical significance increased steadily with increasing exposure volumes. Ultimately, the viability and proliferation of nasal epithelial cells are reduced in a dose-dependent manner when exposed directly to Simmondsia chinensis seed oil. Nasal polyposis, granulation tissue formation after surgery, mucosal hyperplasia, and skin complications following rhinoplasty are among the otolaryngologic disorders that may benefit from the topical antiproliferative effects of Simmondsia chinensis seed oil. More clinical and experimental studies are needed to determine its therapeutic potential and safety profile before it may be used in clinical practice.

Evaluation of the mechanism of gelation of an oleogel based on a triterpene extract from the outer bark of birch [PMID: 23923639 · 2013]
Grysko M, Daniels R · Pharmazie (2013)

Oleogels are known for their high physical, chemical, and mechanical stability and good in vivo efficacy, which make them appropriate vehicles for dermal drug delivery and skin care for very dry skin. Modern formulation research focusses on well tolerated and sustainable formulation concepts. This paper deals with an innovative oleogel, which is based on a triterpene dry extract from the outer bark of birch (TE). In this formulation TE does not only act as an excipient but provides interesting pharmacological properties at the same time. The oleogel was formulated using solely Simmondsia Chinensis seed oil (jojoba oil) and TE. Fluorescence microscopy and confocal Raman microscopy showed that suspended TE particles arrange in a three-dimensional gel network. Infrared spectroscopy revealed that the formation of hydrogen bonds between TE particles is responsible for the self-assembly of TE in oil. Moreover, the influence of TE concentration and morphology of the TE particles on the viscoelasticity of the resulting oleogels was analyzed. Gel strength increased with TE concentration and was critical to the specific surface area of the TE particles.

よくある質問 (FAQ)

Q1. SIMMONDSIA CHINENSIS SEED OIL の各国公式全成分表示名称(7トラック)はどのように異なりますか?
日本化粧品工業連合会(JCIA)表示名称は 'SIMMONDSIA CHINENSIS SEED OIL (標準INCI準拠)'、米国PCPC・欧州CosIng INCIは 'SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL'、中国NMPA IECIC標準中国語名は '中国IECIC未収載(機械翻訳不可)' です。
Q2. SIMMONDSIA CHINENSIS SEED OIL のグローバル6大法域における法定配合基準 (Layer 1) は?
6大法域規制ステータス — 日本(JP): none、韓国(KR): none、欧州(EU): none、米国(US): none、中国(CN): none、ASEAN: none。
Q3. 処方設計における SIMMONDSIA CHINENSIS SEED OIL の通常配合濃度 (Layer 3) と適正 pH は?
主要剤形 (sun_color) において通常 1〜6%(中央値 4%)で配合され、適正pH範囲は 4〜8 です。
Q4. SIMMONDSIA CHINENSIS SEED OIL の配合禁忌 (Incompatibilities) と推奨シナジー成分は?
推奨シナジーペアは GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL、配合上の注意点は Verify phase compatibility under extreme pH or high electrolyte loads です。